Weill Cancer Hub West will harness genomics, big data, AI, and machine learning to counter California’s 20 new cancer cases ...

The 2025 EHA Congress Awards honoured outstanding contributions across clinical care, research, education, and advocacy in ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it responds to treatment.

(RTTNews) - BriaCell Therapeutics Corp. (BCTX), Tuesday announced updated survival data from its ongoing Phase 2 clinical study in patients with metastatic breast cancer, indicating Bria-IMT's ...

At least 180 current and former armed forces aircrew with cancer they claim was caused by exposure to toxic fumes in ...

Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by The Ohio State University Comprehensive ...

Matt Cross, a youth hockey coach and cancer survivor, has turned his personal battle into a mission to educate and inspire others.

Actuate Therapeutics Reports Promising Survival Outcomes in Phase 2 Trial of Elraglusib for Metastatic Pancreatic Cancer ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses and a favorable safety profile.

“Atezolizumab plus mFOLFOX6 is a practice-changing and new standard treatment for patients with dMMR stage III colon cancer,” said Frank Sinicrope, MD.